Disruptive Pharma
PrivateLast Round
M&A
Jun 11, 2026
Est. Valuation
$6.47M
Total Funding Raised
$1.03M
Company Overview
Disruptive Pharma operates in Healthcare & Life Sciences and is based in Uppsala. Its latest recorded funding round was a Corporate Funding round in July 2025.
Disruptive Pharma is a pharmaceutical technology company that develops improved drug formulations using its proprietary Formulite® and Pharma-MMC® mesoporous magnesium carbonate technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Disruptive Pharma Comparables
Compare Disruptive Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeraNovo | 85% | |
| Nanoform Finland Oyj | 77% | |
| Orexo AB | 76% |
For institutional investors. Book with your work email.
Disruptive Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jun 11, 2026 | ||||
| Corporate Funding | Jul 1, 2025 | ||||
| VC Round | Apr 26, 2024 | ||||
| VC Round | Jul 6, 2022 | ||||
| Seed | Jul 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Disruptive Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Uppsala University Invest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Jul 1, 2025
$1.03M raised in corporate funding.
For institutional investors. Book with your work email.
Disruptive Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Disruptive Pharma's valuation, stock price, and market status.
Is Disruptive Pharma a public or private company?
Disruptive Pharma is a private company.
What is the current stock price of Disruptive Pharma?
Disruptive Pharma is a private company, so its shares have no public market price. Caplight tracks Disruptive Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Disruptive Pharma worth (valuation)?
Disruptive Pharma's valuation is estimated at $6.5M based on funding round data.
Can I buy Disruptive Pharma stock?
Disruptive Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Disruptive Pharma's last funding round?
Disruptive Pharma's most recent funding round was M&A on June 11, 2026.
Who are the main investors in Disruptive Pharma?
Key investors in Disruptive Pharma include Uppsala University Invest.
Will Disruptive Pharma IPO soon?
No public IPO plans have been announced for Disruptive Pharma.
How can I track Disruptive Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Disruptive Pharma's shares on secondary markets.